calendar
63 catalysts · 17 phase 2 initiation · 12 phase 2 completion · 4 phase 1 2 initiation · 4 phase 1 initiation · 3 phase 3 initiation · 3 phase 3 completion
next 91 dayslessmore
MonWedFri
63 catalysts · 17 phase 2 initiation · 12 phase 2 completion · 4 phase 1 2 initiation · 4 phase 1 initiation · 3 phase 3 initiation · 3 phase 3 completion
Therapy area: Dermatology. Indication: Unspecified Dermatological Disorders
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Non-Hodgkin Lymphoma, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Oncology. Indication: Lung Cancer
Therapy area: Oncology. Indication: Blood Cancer, Hematological Tumor, Leukemia, Lymphoma
Therapy area: Oncology. Indication: Colorectal Cancer
Therapy area: Oncology. Indication: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Therapy area: Oncology. Indication: Ovarian Cancer
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Recurrent Glioblastoma Multiforme (GBM)
Therapy area: Dermatology. Indication: Diabetic Foot Ulcers
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Dermatology. Indication: Vitiligo
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization, Dry (Atrophic) Macular Degeneration, Geographic Atrophy
Therapy area: Cardiovascular, Dermatology. Indication: Melasma (Chlosma), Venous Thromboembolism